Aller au contenu principal
2018 article

P1‐624: SEX‐RELATED DIFFERENCES IN COGNITIVE IMPAIRMENT AMONG OVERWEIGHT AND OBESE ADULTS WITH TYPE 2 DIABETES

0Citations signalées, ce qui n’est pas une note de qualité
7Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Both type 2 diabetes (T2D) and obesity in mid-life are associated with increased risk for cognitive decline as individuals age. However, it is unknown whether this results in a different prevalence of cognitive impairment for women and men. It is important to understand the nature of any differences because this may provide clues for the prevention of cognitive decline and dementia. The Action for Health in Diabetes study was a randomized controlled clinical trial of a ten-year intensive lifestyle intervention targeting weight loss compared with a control group in overweight and obese adults with T2D. At enrollment, when clinical, behavioral, and demographic risk factors for cognitive decline were assessed, participants were aged 45-76 years. Cases of cognitive impairment (mild cognitive impairment or dementia) were adjudicated following this intervention, an average [range] of 11.4 [9.5,13.5] years after enrollment. We examined whether the prevalence of cognitive impairment at this time varied by sex and, if so, whether differences were attributable to risk factor profiles or responses to the intervention and whether these varied across risk factor subgroups. Cognitive assessments were conducted for 3,802 individuals (61% women). The prevalence of cognitive impairment was 8.3% in women and 14.8% in men (adjusted odds ratio 0.55, 95% confidence interval [0.43,0.71], p<0.001). The odds ratio for women compared with men was fairly constant across the age range of the cohort (p=0.669). Risk factor profiles varied between women and men, but did not account for the difference in prevalence. The sex-related difference in prevalence was limited to individuals without APOE-ε4 alleles (p=0.034) and could not be accounted for by differing responses to the lifestyle intervention -- markers related to weight control (e.g. changes in weight and physical activity) and diabetes control (e.g. HbA1c or medication use) that were altered by the intervention -- or differential follow-up. Among overweight and obese older adults with T2D who were enrolled in a clinical trial of a behavioral intervention, women had a lower prevalence of cognitive impairment than men, which was not explained by traditional risk factors.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
P1‐624: SEX‐RELATED DIFFERENCES IN COGNITIVE IMPAIRMENT AMONG OVERWEIGHT AND OBESE ADULTS WITH TYPE 2 DIABETES
Date Crossref
01/07/2018
Éditeur
Wiley
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Wake Forest University pays non établi dans la notice
    Université ou école supérieure
  • Pennington Biomedical Research Center pays non établi dans la notice
    Structure de recherche
  • Johns Hopkins University pays non établi dans la notice
    Université ou école supérieure
  • Duke University Bryan Alzheimer's Disease Research Center pays non établi dans la notice
    Université ou école supérieure
  • Alzheimer’s Disease Neuroimaging Initiative pays non établi dans la notice
    Organisation à but non lucratif
  • University of Tennessee Health Science Center pays non établi dans la notice
    Université ou école supérieure
  • Mayo Clinic in Florida Department of Health Sciences Research pays non établi dans la notice
    Établissement de santé
  • Wake Forest School of Medicine Winston-Salem NC USA pays non établi dans la notice
    Université ou école supérieure
  • Department of Health Sciences Research Mayo Clinic Rochester MN USA pays non établi dans la notice
    Établissement de santé

Wake Forest University, Pennington Biomedical Research Center et Johns Hopkins University, avec 6 autres affiliations.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Dementia and Cognitive Impairment ResearchNutritional Studies and DietCardiovascular Health and Risk Factors

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.